Activated Pi3k-delta Syndrome
📧 Sign up to get email alerts when something new happens for Activated Pi3k-delta Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI [Phase 2, Phase 3]
Terminated extension study (Phase 2/Phase 3) evaluating CDZ173 in Activated PI3K delta syndrome (APDS) and PASLI disease; results have been …
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome [Phase 1, Phase 2]
This document reports the completion of a Phase 1/2 trial evaluating rapamycin for Activated PI3K-delta syndrome (APDS), a primary immunodef…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: An Open-Label Study to Assess the Safety & Efficacy of Leniolisib in Japanese Patients With APDS [Phase 3]
Open-label Phase 3 trial evaluating safety and efficacy of leniolisib in Japanese patients with APDS (APDS gene mutation).
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI [Phase 2]
Phase 2 safety, PK, and PD study of repeat doses of inhaled nemiralisib in patients with Activated PI3K-delta Syndrome has completed with re…